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1. introduction 
Reports in the literature have indicated that mono- 
nuclear phagocytes may induce coagulation of blood 
[ 1,2]. We have demonstrated the production of the 
vitamin K-dependent coagulation factors, VII, IX, X 
and prothro~nbin by mouse peritoneal lnacrophages 
in vitro [3]. This study shows that these cells also 
synthesize factor V and thromboplastin (tissue fac- 
tor), and thus all the essential proteins of the extrinsic 
coagulation pathway. 
2. Materials and methods 
2.1 . Cell cultures 
Peritoneal cells from mice were obtained and cul- 
tured as in [4]. In some cultures non-adherent cells 
(mainly ly!l~pllocytes~ were removed and the remain- 
ing cells were washed carefully. After this procedure 
the cultures contained <5% lymphocytes, as judged 
by fluorescent microscopy with anti-theta and anti-Ig 
[S]. In other cultures the non-adherent and adherent 
cells were incubated together for 20 h, after which 
non-adllerent cells e95% lymphocytes) were removed 
and tested for thromboplastin activity. In some exper- 
iments T lymphocytes were specifically destroyed by 
the use of a rabbit anti-theta antibody and guinea-pig 
complement [S]. The anti-theta antibody was added 
to the cells ii~~nediately after extraction from the 
peritoneal cavity, and the suspension was incubated 
for 60 min at 0°C. After washing, guinea-pig comple- 
ment was added and the cells were incubated for 
another 45 min at 37°C. Control cells were incubated 
with only anti-theta antibody or with only guinea-pig 
complement. The effectiveness of the anti-theta anti- 
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body and complement was tested by their effect on 
thymus cells and spleen cells from mice IS]. 
The experiments carried out to study thrombo- 
plastic activity were performed with culture media 
containing warfarin (12.5 Erg/ml) to avoid production 
of factor VII and factor X. In some experiments endo- 
toxin (I?. c&i lipopoiysaccharide O%:Bti, Boivin 
preparation, Difco Labs., Detroit MI) was added to the 
tissue culture medium at 10 pg/ml final cont. 
2.2. Factor V assays 
Factor V was assayed in either a one stage clotting 
assay as in [7] or in a coupled amidolytic assay. The 
coupled amidolytic assay was based on the require- 
ment for factor V in the conversion of prothrombin 
to thrombin by factor Xa in the presence of phospho- 
lipid. The generated thrombin was quantitated by the 
use of a chromogenic substrate, S-2238 (KabiVitrum 
AB, Stoc~o~). The assay was carried out by incu- 
bating 50 ~1 factor Xa ([8], 0.4 U/ml), 50 ~1 pro- 
thrombin (1.5 U/ml), and 50 ~1 cephalin [9] at 37°C 
for 1 min. After the addition of 50 ~1 test sample, 
and 20 ~150 mM CaCl, the incubation was continued 
for another 3 min. The reaction was stopped by adding 
10 ~10.3 M Na,-EDTA. An aliquot of 100 ~1 incuba- 
tion mixture was mixed with 600 ~10.05 M TrissHCl 
(pH 7.4) containing 0.1 M NaCl, and 100 ~1 S-2238 
(1 mg/ml). The amount of thrombin generated was 
determined by measuring the rate of increase of 
absorbance at 405 nm. Prothrombin was purified by 
methods similar to those used for the purification of 
factor X [8] with one modification. The pooled pro- 
thrombin fractions from the preparative polyacryl- 
amide gel electrophoresis were diluted 1:3 with water 
and applied to a dextran sulphate-Sepharose column 
(1.5 cm X 10 cm). The colutnn was eluted with a gra- 
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dient of O-0.05 M NaCl in 0.0 1 M Hepes (pH 7.4). 
Prothrombin obtained by this method gave a single 
band on SDS-polyacrylamide gel electrophoresis and 
contained no other coagulation factor activities. 
2.3. Thrombophtin assay 
Thromboplastin was quantitated in a two-stage 
assay based on the principle that thromboplastin is 
the limiting factor in the activation of factor X in a 
system consisting of purified factor X, factor VII, and 
Ca2’. The assay was initiated by incubating 25 ~1 fac- 
torX([8],2.7 U/ml)and25~lfactorVII([10], 
0.7 U/ml) at 37°C. After 1 min 100 ~1 of test sample 
and 20 ~150 mM CaCl, were added, and the incuba- 
tion was continued for 10 min. An aliquot of 50 ~1 
was then removed, and the amount of factor Xa gen- 
erated was assayed by utilizing the chromogenic sub- 
strate S-2222 (KabiVitrum AB). Rabbit anti-human 
thromboplastin [6] was kindly provided by Dr E. 
Bjsrklid, Tromss. 
3. Results 
Spent media from cultures of adherent cells con- 
tained significant amounts of factor V when tested in 
a one stage clotting assay. With media collected after 
24 h cell culture a clotting time of 65 s was obtained 
as compared to 135 s with a control medium, incu- 
bated without cells. A similar sample, analyzed by a 
coupled amidolytic assay, showed a factor V activity 
corresponding to 0.5% of the activity in normal plasma 
(fig.1). In this procedure the addition of factor Xa is 
a prerequisite to the formation of thrombin. Accord- 
ingly , no significant amounts of thrombin could be 
detected in the absence of this factor, thus excluding 
the presence of any agent capable of activating pro- 
thrombin directly. As predicted, the production of 
factor V was unaffected by the presence of warfarin 
in the culture medium, but was greatly reduced in the 
presence of cycloheximide. Contrary to the formation 
of thromboplastin (see below) the production of fac- 
tor V was unaffected by the addition of endotoxin, 
nor did it require the presence of non-adherent cells 
(not shown). 
In [3] we found that factor X produced by cul- 
tured mouse peritoneal macrophages occurred par- 
tially in activated form (Xa) and that the extent of 
activation varied with the number of lymphocytes 
present [3]. These results could only be explained by 
Table 1 
Tissue thromboplastin activity in peritoneal cells 
Culture conditions Factor Xa formed (%) 
Adherent cells 
Adherent cells 
2.7 * 0.7 
+ endotoxin 
Adherent cells 
14.7 * 1.9 
+01e +c 
Adherent cells 
0.5 * 0.2 
t 010 t C t endotoxin 
Nonadherent cells 
Non-adherent cells 
0.9 + 0.3 
<O.l t 0 
+ endotoxin 0.1 f 0 
Peritoneal cells were obtained as in section 2. After 2 h in cul- 
ture, non-adherent cells (mainly lymphocytes) were removed 
by washing, and the remaining adherent cells (mainly macro- 
phages) were cultivated separately overnight and thereafter 
lysed by repeated freezing and thawing and thromboplastin 
was determined in a coupled amidolytic assay. Results are 
expressed as the amount of Xa formed relative to a fully acti- 
vated pooled plasma standard +SD. The anti-theta antibody 
(a,?) and complement (C)were added immediately after 
extraction of the cells from the peritoneal cavity, whereas 
endotoxin was added after separation of the adherent and 
non-adherent cells. The adherent cells represented >95c/o 
macrophages, with a <5% contamination by T and B lympho- 
cytes as judged by fluorescence microscopy. For additional 
details see section 2 
0.6 
g 0.5 
I 
Fig.1. Adherent cells (>95% macrophages) were cultured for 
24 h in media containing either 12.5 pg warfarin/ml, or 5 wg 
cycloheximide/ml, or no added inhibitor (control). The cells 
were centrifuged, and the resulting supernatants were tested 
for factor V as in section 2. The results are expressed as the 
amount of factor V activity relative to pooled, normal human 
plasma. Media from cultures of non-adherent cells (>95% 
lymphocytes) grown in the absence of any inhibitor contained 
0 .O 1% factor V activity. 
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assuming the production of thromboplastin (tissue 
factor) in the cell cultures. Such production was 
demonstrated here, using a specific, reproducible and 
highly sensitive, coupled amidolytic assay. Table 1 
shows that adherent cells (>95% macrophages) pro- 
duced thromboplastin whereas non-adherent cells 
(>95% lymphocytes) did not. However, the few 
adherent lymphocytes were apparently essential to 
the production of thromboplastin, as shown by the 
effects of adding anti-theta antibody and complement 
to the cultures. Moreover, the formation of thrombo- 
plastin was greatly enhanced by the presence of endo- 
toxin; this effect was also dependent on lymphocytes. 
The thromboplastin activity in the cell cultures 
could be blocked by rabbit anti-human thromboplas- 
tin. In a representative xperiment, 28% factor Xa 
(table 1 legend) was generated in a culture stimulated 
by endotoxin, whereas only 0.3% factor Xa was gen- 
erated in a parallel incubation with anti-thromboplas- 
tin antibody. This experiment provides conclusive evi- 
dence that the factor measured in the coupled ami- 
dolytic assay employed is indeed thromboplastin and 
not some other component capable of activating fac- 
tor X. 
4. Discussion 
These results, along with those in [3], show that 
mouse peritoneal macrophages produce all the pro- 
teins that constitute the extrinsic blood coagulation 
system. The activation of this system, expressed by 
the formation of factor Xa from endogenous factor X 
[3], requires the presence of thromboplastin. Since 
factor Xa is secreted to the culture medium [3] 
whereas the thromboplastin is confined to the cells, 
it appears likely that the interaction between factor X 
and thromboplastin is an intracellular process. 
Thromboplastin activity has been shown in mono- 
cytes [ 11 ,121 and procoagulant activity in spleen 
macrophages [2]. Our results agree with [2] in show- 
ing a requirement for lymphocytes and a stimulatory 
effect of endotoxin. However, there is one notable 
difference. Here, a drastic increase in thromboplastin 
activity was obtained on adding endotoxin to macro- 
phage cultures containing <5% lymphocytes. By con- 
trast, in [2] showed no stimulatory effect of endo- 
toxin at lymphocyte :macrophage ratios <3 : 1. While 
the reason for this discrepancy is unknown, it may be 
relevant to point out that the sensitivity of our throm- 
boplastin assay exceeds that used in [2] by -2 orders 
of magnitude. 
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